SB431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma xenograft malignant phenotype.
Publication
, Conference
Hjelmeland, MD; Herbstreith, M; Sathornsumetee, S; Hjelmeland, A; Laping, NJ; Bigner, DD; Wang, XF; Rich, JN
Published in: CLINICAL CANCER RESEARCH
December 1, 2003
Duke Scholars
Published In
CLINICAL CANCER RESEARCH
ISSN
1078-0432
Publication Date
December 1, 2003
Volume
9
Issue
16
Start / End Page
6236S / 6236S
Location
BOSTON, MASSACHUSETTS
Publisher
AMER ASSOC CANCER RESEARCH
Conference Name
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Hjelmeland, M. D., Herbstreith, M., Sathornsumetee, S., Hjelmeland, A., Laping, N. J., Bigner, D. D., … Rich, J. N. (2003). SB431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma xenograft malignant phenotype. In CLINICAL CANCER RESEARCH (Vol. 9, pp. 6236S-6236S). BOSTON, MASSACHUSETTS: AMER ASSOC CANCER RESEARCH.
Hjelmeland, M. D., M. Herbstreith, S. Sathornsumetee, A. Hjelmeland, N. J. Laping, D. D. Bigner, X. F. Wang, and J. N. Rich. “SB431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma xenograft malignant phenotype.” In CLINICAL CANCER RESEARCH, 9:6236S-6236S. AMER ASSOC CANCER RESEARCH, 2003.
Hjelmeland MD, Herbstreith M, Sathornsumetee S, Hjelmeland A, Laping NJ, Bigner DD, et al. SB431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma xenograft malignant phenotype. In: CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2003. p. 6236S-6236S.
Hjelmeland, M. D., et al. “SB431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma xenograft malignant phenotype.” CLINICAL CANCER RESEARCH, vol. 9, no. 16, AMER ASSOC CANCER RESEARCH, 2003, pp. 6236S-6236S.
Hjelmeland MD, Herbstreith M, Sathornsumetee S, Hjelmeland A, Laping NJ, Bigner DD, Wang XF, Rich JN. SB431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma xenograft malignant phenotype. CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2003. p. 6236S-6236S.
Published In
CLINICAL CANCER RESEARCH
ISSN
1078-0432
Publication Date
December 1, 2003
Volume
9
Issue
16
Start / End Page
6236S / 6236S
Location
BOSTON, MASSACHUSETTS
Publisher
AMER ASSOC CANCER RESEARCH
Conference Name
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis